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Résumé en
anglais
BACKGROUND: There is currently a lack of consensus on how health-related quality of
life and other patient-reported outcome measures in cancer randomized clinical trials
are analyzed and interpreted. This makes it difficult to compare results across
randomized controlled trials (RCTs) synthesize scientific research, and use that
evidence to inform product labeling, clinical guidelines, and health policy. The Setting
International Standards in Analyzing Patient-Reported Outcomes and Quality of Life
Endpoints Data for Cancer Clinical Trials (SISAQOL) Consortium aims to develop
guidelines and recommendations to standardize analyses of patient-reported outcome
data in cancer RCTs.
METHODS AND RESULTS: Members from the SISAQOL Consortium met in January
2017 to discuss relevant issues. Data from systematic reviews of the current state of
published research in patient-reported outcomes in cancer RCTs indicated a lack of
clear reporting of research hypothesis and analytic strategies, and inconsistency in
definitions of terms, including "missing data,"health-related quality of life," and
"patient-reported outcome." Based on the meeting proceedings, the Consortium will
focus on three key priorities in the coming year: developing a taxonomy of research
objectives, identifying appropriate statistical methods to analyze patient-reported
outcome data, and determining best practices to evaluate and deal with missing data.
CONCLUSION: The quality of the Consortium guidelines and recommendations are
informed and enhanced by the broad Consortium membership which includes
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